The t(14;18)(q32;q21) Characterizes a Subset of Patients with Diffuse Large-B Cell Lymphoma of Germinal Center Origin with Poor Outcome: Report From the International DLBCL Rituximab-CHOP Consortium Program StudyCarlo Visco, Ken H. Young, Fan Zhou et al.|Blood|2011Cited by 5
Radiation Therapy Significantly Improves Survival Of Patients With Diffuse Large B-Cell Lymphoma Associated With MYC Translocation: A Report From The International DLBCL Rituximab-CHOP Consortium ProgramZijun Y. Xu‐Monette, Ken H. Young, Bouthaina S. Dabaja et al.|Blood|2013Cited by 2
Cell of Origin Classification of DLBCL Using Targeted NGS Expression Profiling and Deep LearningMaher Albitar, Ken H. Young, Zijun Y. Xu‐Monette et al.|Blood|2019Cited by 2
Higher Stability of Mutant mRNA As Compared to Wild-Type mRNA in Diffuse Large B-Cell LymphomaMaher Albitar, Ken H. Young, Zijun Y. Xu‐Monette et al.|Blood|2019Cited by 2
Determining Clinical Course of Diffuse Large B-Cell Lymphoma Using Targeted Transcriptome and Machine Learning AlgorithmsMaher Albitar, Ken H. Young, Hong Zhang et al.|Blood|2021Cited by 2